ErlotinibRash and gastrointestinal toxicities: 24 case reports

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2020年 / 1832卷 / 1期

关键词：

D O I：

10.1007/s40278-020-86672-x

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：139 / 139

相关论文

共 50 条

[21] Multiple drugsVarious ocular toxicities: 24 case reports
[J]. Reactions Weekly, 2021, 1876 (1) : 242 - 242
[22] Ipilimumab/nivolumab/pembrolizumabVarious toxicities: 24 case reports
[J]. Reactions Weekly, 2023, 1954 (1) : 262 - 262
[23] Atezolizumab/nivolumab/pembrolizumabVarious toxicities: 24 case reports
[J]. Reactions Weekly, 2022, 1924 (1) : 94 - 94
[24] Bevacizumab/erlotinibRash and intratumoural haemorrhage: 4 case reports
[J]. Reactions Weekly, 2013, 1451 (1) : 11 - 11
[25] ErlotinibRash, diarrhoea, pain and alopecia: 2 case reports
[J]. Reactions Weekly, 2014, 1513 (1) : 19 - 19
[26] Docetaxel/gemcitabineFatigue, gastrointestinal and haematological toxicities: 4 case reports
[J]. Reactions Weekly, 2019, 1752 (1) : 140 - 140
[27] Botulinum toxin-AVarious toxicities: 24 case reports
[J]. Reactions Weekly, 2020, 1798 (1) : 67 - 67
[28] Ipilimumab/nivolumabVarious toxicities and lack of efficacy: 24 case reports
[J]. Reactions Weekly, 2024, 2024 (1) : 244 - 244
[29] Covid-19-vaccineVarious toxicities: 24 case reports
[J]. Reactions Weekly, 2023, 1986 (1) : 151 - 151
[30] Ketorolac/Opioid-analgesicsVarious toxicities: 24 case reports
[J]. Reactions Weekly, 2020, 1818 (1) : 161 - 161

← 1 2 3 4 5 →